8 Results for "

KMT9

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "KMT9" in MCE Product Catalog:

Cat. No.: HY-157486
Purity:  98.00%
Research Areas:  

Cancer

KMI169 is a potent and selective inhibitor targeting lysine methyl-transferase (KMT9) (IC50 = 0.05 μM, Kd = 0.025 μM). KMI169 functions as a bi-substrate inhibitor targeting the cofactor S-5’-adenosyl-L-methionine (SAM) and substrate binding pockets of KMT9. KMI169 can downregulate target genes involved in cell cycle regulation and impair proliferation of tumor cells by inhibiting KMT9. KMI169 is a valuable tool to probe cellular KMT9 functions and can be research for combating diseases including prostate, lung, colon, and invasive bladder cancer .
loading...
    loading...
Cat. No.: HY-174450
CAS No.: 2625406-61-1
Research Areas:  

Cancer

KMT9-IN-1 (Compound 8) is a KMT9 inhibitor and the ethyl ester prodrug of compound 7b. KMT9-IN-1 releases the active form 7b via esterases in cells. KMT9-IN-1 targets KMT9 in cells and reduces H4K12me1 levels. KMT9-IN-1 has antitumor activity against colon cancer. KMT9-IN-1 can be used in the research of prostate cancer and hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-174451
Research Areas:  

Cancer

KMT9-IN-2 (Compound 7b) is an active form of a KMT9 inhibitor (Kd of 10 nM). KMT9-IN-2 can be used in the research of colon cancer .
loading...
    loading...
Cat. No.: HY-P77376
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HEMK2; N-6 Adenine-Specific DNA Methyltransferase 1 (Putative); Prev. C21orf127; Methylarsonite Methyltransferase N6AMT1; Prev. N6AMT1; Lysine N-Methyltransferase 9; PRED28; Methyltransferase N6AMT1; KMT9; Methyltransferase HEMK2; HemK Methyltransferase F
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS08984
Research Areas:  

Others

N6AMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for N6AMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P703465
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TRMT112; AD-001; HSPC152; HSPC170; Multifunctional methyltransferase subunit TRM112-like protein; tRNA methyltransferase 112 homolog; TRM112; HTrm112; TRMT11-2; TRNA Methyltransferase Activator Subunit 11-2; TRM112-Like Protein; TRNA Methyltransferase 11-2 Homolog; TRNA Methyltransferase 11-2 Homolog (S. Cerevisiae); TRNA Methyltransferase Subunit 11-2; HEMK2; N-6 Adenine-Specific DNA Methyltransferase 1 (Putative); Prev. C21orf127; Methylarsonite Methyltransferase N6AMT1; Prev. N6AMT1; Lysine N-Methyltransferase 9; PRED28; Methyltransferase N6AMT1; KMT9; Methyltransferase HEMK2; HemK Methyltransferase Family Member 2; M.HsaHemK2P; N6AMT; N-6 Adenine-Specific DNA Methyltransferase 1; MTQ2; Chromosome 21 Open Reading Frame 127; PrmC; N6-DNA-Methyltransferase; HemK Methyltransferase 2, ETF1 Glutamine And Histone H4 Lysine; Protein N(5)-Glutamine Methyltransferase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-183602
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

FRC-303 is a CHD1 inhibitor with a Kd of 0.14 μM and an IC50 of 0.18 μM. FRC-303 binds to the H3K4me3 binding site of CHD1 tandem chromodomain, forms aromatic cage interactions and extended ligand contacts, acts as a methyl-lysine mimic, and occupies natural peptide ligand-binding regions. FRC-303 can be used for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-183603
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

FRC-222 is a CHD1 tandem chromodomain inhibitor with a Kd of 0.15 μM and an IC50 of 0.18 μM. FRC-222 binds to the H3K4me3 binding site of CHD1 tandem chromodomain via aromatic cage interactions and extended ligand contacts. FRC-222 can be used for the research of prostate cancer[1].
loading...
    loading...